Finally, experimental validation in HBx-expressing HepG2 cells and HBV-infected HCC tissues confirmed elevated DNTTIP2 expression, supporting its role in shaping an immunosuppressive TME. This evidence concerns the gene DNTTIP2 and hepatocellular carcinoma.